112 related articles for article (PubMed ID: 15860896)
1. Safety of exemestane in the Intergroup Exemestane Study.
Coombes RC; Bliss JM; Hall E
J Clin Oncol; 2005 May; 23(13):3171-2. PubMed ID: 15860896
[No Abstract] [Full Text] [Related]
2. Aromatase inhibitors and bone loss: risks in perspective.
Shapiro CL
J Clin Oncol; 2005 Aug; 23(22):4847-9. PubMed ID: 15983395
[No Abstract] [Full Text] [Related]
3. Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane.
Gonnelli S; Cadirni A; Caffarelli C; Petrioli R; Montagnani A; Franci MB; Lucani B; Francini G; Nuti R
Bone; 2007 Jan; 40(1):205-10. PubMed ID: 16904960
[TBL] [Abstract][Full Text] [Related]
4. Exemestane following tamoxifen in postmenopausal women with primary breast cancer.
Mouridsen HT
J Clin Oncol; 2004 Sep; 22(18):3833-4. PubMed ID: 15365083
[No Abstract] [Full Text] [Related]
5. Drug safety evaluation of exemestane.
Lintermans A; Neven P; Paridaens R
Expert Opin Drug Saf; 2011 May; 10(3):473-87. PubMed ID: 21428848
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant treatment of breast cancer with exemestane.
Tanvetyanon T
N Engl J Med; 2004 Jul; 351(1):100-2; author reply 100-2. PubMed ID: 15237463
[No Abstract] [Full Text] [Related]
7. Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer.
Lønning PE; Geisler J; Krag LE; Erikstein B; Bremnes Y; Hagen AI; Schlichting E; Lien EA; Ofjord ES; Paolini J; Polli A; Massimini G
J Clin Oncol; 2005 Aug; 23(22):5126-37. PubMed ID: 15983390
[TBL] [Abstract][Full Text] [Related]
8. Switch to exemestane effective in early breast cancer.
Gourd E
Lancet Oncol; 2017 Jun; 18(6):e308. PubMed ID: 28506558
[No Abstract] [Full Text] [Related]
9. Exemestane or tamoxifen?
Ueda M; Toji E; Noda S
Lancet; 2007 May; 369(9573):1600; author reply 1600-1. PubMed ID: 17499595
[No Abstract] [Full Text] [Related]
10. Exemestane: a milestone against breast cancer.
Shetty YC; Chakkarwar PN; Acharya SS; Rajadhyaksha VD
J Postgrad Med; 2007; 53(2):135-8. PubMed ID: 17495383
[TBL] [Abstract][Full Text] [Related]
11. [ASCO 2006. Exemestane: a new drug for the adjuvant therapy of breast cancer].
Perrone F
Tumori; 2006; 92(4):suppl 1-9. PubMed ID: 17036536
[No Abstract] [Full Text] [Related]
12. Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.
Coombes RC; Kilburn LS; Snowdon CF; Paridaens R; Coleman RE; Jones SE; Jassem J; Van de Velde CJ; Delozier T; Alvarez I; Del Mastro L; Ortmann O; Diedrich K; Coates AS; Bajetta E; Holmberg SB; Dodwell D; Mickiewicz E; Andersen J; Lønning PE; Cocconi G; Forbes J; Castiglione M; Stuart N; Stewart A; Fallowfield LJ; Bertelli G; Hall E; Bogle RG; Carpentieri M; Colajori E; Subar M; Ireland E; Bliss JM;
Lancet; 2007 Feb; 369(9561):559-70. PubMed ID: 17307102
[TBL] [Abstract][Full Text] [Related]
13. National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: evaluation of exemestane to prevent breast cancer in postmenopausal women.
Goss PE; Richardson H; Chlebowski R; Johnston D; Sarto GE; Maunsell E; Ingle JN; Alés-Martinez JE
Clin Breast Cancer; 2007 Dec; 7(11):895-900. PubMed ID: 18269782
[No Abstract] [Full Text] [Related]
14. Can exemestane improve adjuvant treatment for postmenopausal women with primary breast cancer?
Hutchinson L
Nat Clin Pract Oncol; 2004 Nov; 1(1):24-5. PubMed ID: 16264795
[No Abstract] [Full Text] [Related]
15. To switch or not to switch: should the updated Intergroup Exemestane Study alter our decision?
Iddon J; Bundred NJ
Expert Rev Anticancer Ther; 2008 Jan; 8(1):9-13. PubMed ID: 18095878
[TBL] [Abstract][Full Text] [Related]
16. Exemestane: a novel aromatase inactivator for breast cancer.
Jones SA; Jones SE
Clin Breast Cancer; 2000 Oct; 1(3):211-6. PubMed ID: 11899645
[TBL] [Abstract][Full Text] [Related]
17. Exemestane or tamoxifen?
Ferretti G; Felici A; Carlini P; Cognetti F
Lancet; 2007 May; 369(9573):1599; author reply 1600-1. PubMed ID: 17499594
[No Abstract] [Full Text] [Related]
18. Cancer: some reasons to be hopeful.
Lancet; 2007 Feb; 369(9561):531. PubMed ID: 17307079
[No Abstract] [Full Text] [Related]
19. Exemestane for advanced breast cancer.
Med Lett Drugs Ther; 2000 Apr; 42(1076):35-6. PubMed ID: 10803175
[No Abstract] [Full Text] [Related]
20. Exemestane: new preparation. No tangible advance in metastatic breast cancer after tamoxifen failure.
Prescrire Int; 2001 Aug; 10(54):108-9. PubMed ID: 11718178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
